ResearcherUniversité de StrasbourgActive in the last 2 years
Philippe Bachellier
Matched on ORCID iD 0000-0003-1090-6749; OpenAlex author ID A5030179336, A5035175916. Sources: OpenAlex.
Their work
- Papers
- 20 (first author 1, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 115
2011: 2 papers · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: 2 papers · 2016: 1 paper · 2017: 3 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 3 papers · 2026: 1 paper
Papers 20
- Futility in adenosquamous pancreatic cancer. Co-author DOI 10.1186/s12957-026-04351-1↗
- Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000006779↗
- Distal Pancreatectomy with Celiac Axis and Venous Resection with Hepatic Artery and Venous Reconstruction (DP-CARV) for Locally Advanced Pancreatic Adenocarcin… Last author DOI 10.1245/s10434-024-16623-9↗
- Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter T… Last author DOI 10.1245/s10434-024-16735-2↗
- REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006248↗
- Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcomes of Curative Intent Surgery: A Study o… Co-author DOI 10.1007/s00268-021-06205-1↗
- Response to the Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?" Last author DOI 10.1097/sla.0000000000004408↗
- Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution's Experience Wit… Co-author DOI 10.1097/sla.0000000000003010↗
- Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. Co-author DOI 10.1093/jnci/djz073↗
- Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two different diseases receive the same treatment?… Co-author DOI 10.1016/j.ejso.2017.06.011↗
- Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters. Last author DOI 10.1016/j.surg.2017.03.008↗
- Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. Co-author DOI 10.1186/s12916-017-0810-z↗
- Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a mu… Co-author DOI 10.1186/s12885-016-2860-6↗
- Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.jamcollsurg.2015.03.058↗
- Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Associati… Co-author DOI 10.1245/s10434-014-4304-3↗
- Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal… Co-author DOI 10.1016/j.surg.2013.09.003↗
- Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. First author DOI 10.1111/hpb.12061↗
- A safe technique for radical antegrade modular pancreatosplenectomy with venous resection for pancreatic cancer. Last author DOI 10.1016/j.jamcollsurg.2013.08.007↗
- Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled stud… Co-author DOI 10.1002/jso.21769↗
- Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III s… Co-author DOI 10.1186/1471-2407-11-346↗
Closest collaborators
The 25 strongest of 115 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pietro Addeo Md · 10 shared papers, 2013–2026 · strength 1.56
- Paper Distal Pancreatectomy with Celiac Axis and Venous Resection with Hepatic Artery and Venous Reconstruction (DP-CARV) for… DOI 10.1245/s10434-024-16623-9↗
- Paper Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Ad… DOI 10.1097/sla.0000000000006779↗
- Paper Response to the Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Sa… DOI 10.1097/sla.0000000000004408↗
- Gerlinde Avérous · 4 shared papers, 2017–2025 · strength 0.63
- Paper Prognostic Impact of type of Arterial Resection on Outcomes of Pancreatectomy with Arterial Resection for Pancreatic Ad… DOI 10.1097/sla.0000000000006779↗
- Paper Response to the Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Sa… DOI 10.1097/sla.0000000000004408↗
- Paper Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. DOI 10.1186/s12916-017-0810-z↗
- Alain Sauvanet Sauvanet · 6 shared papers, 2014–2025 · strength 0.48
- Paper Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma … DOI 10.1245/s10434-024-16735-2↗
- Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
- Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
- Gennaro Nappo · 3 shared papers, 2017–2026 · strength 0.40
- Paper Futility in adenosquamous pancreatic cancer. DOI 10.1186/s12957-026-04351-1↗
- Paper Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes… DOI 10.1097/sla.0000000000003010↗
- Paper Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters. DOI 10.1016/j.surg.2017.03.008↗
- Jean‐Robert Delpéro · 6 shared papers, 2011–2021 · strength 0.34
- Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
- Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
- Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
- Julie Navez · 2 shared papers, 2025–2026 · strength 0.34
- François Paye · 5 shared papers, 2014–2021 · strength 0.32
- Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
- Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
- Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
- Mustapha Adham · 3 shared papers, 2015–2021 · strength 0.23
- Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
- Paper Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two differ… DOI 10.1016/j.ejso.2017.06.011↗
- Paper Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pan… DOI 10.1016/j.jamcollsurg.2015.03.058↗
- Cristina Vallejo Bernad · 1 shared paper, 2026 · strength 0.18
- Bodil Andersson · 1 shared paper, 2026 · strength 0.18
- Bergþór Björnsson · 1 shared paper, 2026 · strength 0.18
- Santiago Sánchez-Cabús · 1 shared paper, 2026 · strength 0.18
- Sebastian Manuel Staubli · 1 shared paper, 2026 · strength 0.18
- Dimitrios E. Giakoustidis · 1 shared paper, 2026 · strength 0.18
- Maria João Amaral · 1 shared paper, 2026 · strength 0.18
- Anita Balakrishnan · 1 shared paper, 2026 · strength 0.18
- Alessandro Zerbi · 1 shared paper, 2026 · strength 0.18
- Dimitrios Lytras · 1 shared paper, 2026 · strength 0.18
- José Manuel Ramia · 1 shared paper, 2026 · strength 0.18
- Sanjay Pandanaboyana · 1 shared paper, 2026 · strength 0.18
- Gerardo Blanco‐Fernández · 1 shared paper, 2026 · strength 0.18
- Mario Serradilla-Martín · 1 shared paper, 2026 · strength 0.18
- Jakob Kirkegård · 1 shared paper, 2026 · strength 0.18
- Juli Busquets · 1 shared paper, 2026 · strength 0.18
- Ahmad Mahamid · 1 shared paper, 2026 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.